Comment on

• Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.

  Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW; AIDS Clinical Trials Group 398 Study Team. Hammer SM, et al. JAMA. 2002 Jul 10;288(2):169-80. doi: 10.1001/jama.288.2.169. JAMA. 2002. PMID: 12095381 Clinical Trial.
• Time trends in primary HIV-1 drug resistance among recently infected persons.

  Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO. Grant RM, et al. JAMA. 2002 Jul 10;288(2):181-8. doi: 10.1001/jama.288.2.181. JAMA. 2002. PMID: 12095382